These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 18713462)
21. High level of Sema3C is associated with glioma malignancy. Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848 [TBL] [Abstract][Full Text] [Related]
22. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492 [TBL] [Abstract][Full Text] [Related]
23. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596 [TBL] [Abstract][Full Text] [Related]
24. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas. Wang M; Tang J; Liu S; Yoshida D; Teramoto A J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas. Hara A; Yamada H; Sakai N; Hirayama H; Tanaka T; Mori H Cancer; 1990 Dec; 66(12):2563-8. PubMed ID: 2174303 [TBL] [Abstract][Full Text] [Related]
29. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. van den Boom J; Wolter M; Kuick R; Misek DE; Youkilis AS; Wechsler DS; Sommer C; Reifenberger G; Hanash SM Am J Pathol; 2003 Sep; 163(3):1033-43. PubMed ID: 12937144 [TBL] [Abstract][Full Text] [Related]
30. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma. Kristt DA; Reedy E; Yarden Y Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190 [TBL] [Abstract][Full Text] [Related]
31. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Lehman NL; O'Donnell JP; Whiteley LJ; Stapp RT; Lehman TD; Roszka KM; Schultz LR; Williams CJ; Mikkelsen T; Brown SL; Ecsedy JA; Poisson LM Cell Cycle; 2012 Feb; 11(3):489-502. PubMed ID: 22274399 [TBL] [Abstract][Full Text] [Related]
32. Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403 [TBL] [Abstract][Full Text] [Related]
33. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400 [TBL] [Abstract][Full Text] [Related]
34. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas. Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509 [TBL] [Abstract][Full Text] [Related]
36. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987 [TBL] [Abstract][Full Text] [Related]
37. Class I histone deacetylase expression in the human cyclic endometrium and endometrial adenocarcinomas. Krusche CA; Vloet AJ; Classen-Linke I; von Rango U; Beier HM; Alfer J Hum Reprod; 2007 Nov; 22(11):2956-66. PubMed ID: 17728353 [TBL] [Abstract][Full Text] [Related]
38. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611 [TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry. Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669 [TBL] [Abstract][Full Text] [Related]
40. DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas. Schmidt N; Windmann S; Reifenberger G; Riemenschneider MJ Brain Pathol; 2012 Jan; 22(1):17-25. PubMed ID: 21631628 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]